phone
phone
- February 2019
-
Biobanking Market By Product and service (Consumables, Services, Equipment, Software), Sample Type (Human Tissues, Nucleic Acids, Cell Lines, Blood Products, Biological Fluids, Human Waste Products), Application (Regenerative Medicine, Life Science Research, Clinical Research), Industry Trends, Estimation & Forecast, 2017 - 2025
Check Today's Best Price
$3500
Buy Now
This report studies Biobanking in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2025.
-
keyboard_arrow_up
Biobanking is the collection and preservation of biological material used for diagnosis, biodiversity studies, and research. Biobanks play a fundamental role in supporting biomedical research studies, developing personalized medicine and for maintaining and updating age demographic databases. Biological samples such as purified saliva, blood, plasma, DNA samples are collected systematically from patients and various other donors. The rising incidents of blood disorders and the surging demand for various types of blood products across the globe, are driving the growth of biobanking market.
Biobanking Market Determinants
The key factors driving the growth of global biobanking market are the advances in drug discovery & regenerative medicine, and rising investments from the government & non-government organizations. NIH is the major source of funding and facilitator for many Biobanks across the U.S. Moreover, rising demand for personalized medicines and the growing trend of preserving cord blood stem cells of newborns are also driving the market growth. On the other hand,, the stringent regulations regarding biospecimen sample procurement and costly techniques involved act as the major hurdles in the growth of the market. However, increasing government initiatives and rising interest of pharmaceutical & biotechnology companies in biobanking sector are expected to create huge opportunities for the growth of market in the coming years.
Biobanking Market Segmentation
By Product and service
• Consumables
• Services
• Equipment
• SoftwareBy Sample Type
• Human Tissues
• Nucleic Acids
• Cell Lines
• Blood Products
• Biological Fluids
• Human Waste ProductsBy Application
• Regenerative Medicine
• Life Science Research
• Clinical ResearchBy Geography
• North America
o U.S.
o Canada• Europe
o France
o Germany
o Italy
o Netherlands
o U.K.
o Rest of Europe• Asia-Pacific
o China
o Japan
o India
o Australia
o Rest of Asia-Pacific• Rest of the World
o Latin America
o Middle East
o Africa -
keyboard_arrow_up
Table of Content
-
keyboard_arrow_up
• Promega Corporation
• Tecan Group Ltd.
• Qiagen N.V.
• Hamilton Company
• Merck KGaA
• Brooks Automation
• TTP Labtech Ltd
• VWR Corporation
• Chart Industries Inc.
• Becton
• Dickinson and Company
• LVL Technologies GmbH & Co. KG
• Greiner Bio-One
• Biokryo GmbH
• Biobank AS
• Thermo Fisher Scientific Inc.
• Biorep Technologies Inc.
• Cell & Co Bioservices
• RUCDR infinite biologics
• Worthington Industries
• Modul-Bio
• LabVantage Solutions Inc. -
What Information does this report contain?
• What was the market size of the Biobanking Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Biobanking Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?
